(Q38061567)

English

Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

1 reference

Europe PubMed Central

Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

arterial hypertension

0 references

author name string

Evan Berry

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Ana-Maria Bosonea

2

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Xiang Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Carlos Fernandez-Patron

4

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

publication date

17 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Journal of Vascular Research

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

52-68

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension?

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Therapeutic potential of the epidermal growth factor receptor transactivation in hypertension: a convergent signaling pathway of vascular tone, oxidative stress, and hypertrophic growth downstream of vasoactive G-protein-coupled receptors?

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Molecular mechanisms of human hypertension

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Role for ADAM-family proteinases as membrane protein secretases.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The role of ADAM-mediated shedding in vascular biology.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Multiple roles of the extracellular matrix in inflammation

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

ADAM-17 regulates endothelial cell morphology, proliferation, and in vitro angiogenesis

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinase-2: the forgotten enzyme in aneurysm pathogenesis

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Metalloproteinases in development and progression of vascular disease

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Diversity of myocardial interstitial proteolytic pathways: gene deletion reveals unexpected consequences

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinase therapy in heart failure

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

MMP-2 Mediates Angiotensin II–Induced Hypertension Under the Transcriptional Control of MMP-7 and TACE

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesis

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Vascular responses to alpha1-adrenergic receptors in small rat mesenteric arteries depend on mitochondrial reactive oxygen species

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

AP-1: a double-edged sword in tumorigenesis

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

NFkappaB-dependent signaling pathways

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Nuclear factor kappa B and matrix metalloproteinase induced receptor cleavage in the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Inflammation, immunity, and hypertension

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The ADAM metalloproteinases

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Regulation of matrix metalloproteinase activity

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasion

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Mitochondrial formation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodelling

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Tissue inhibitors of metalloproteinases

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Inhibition of Na+/Ca2+ exchanger by peroxynitrite in microsomes of pulmonary smooth muscle: role of matrix metalloproteinase-2.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinases: a tail of a frog that became a prince

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Endocytosis unplugged: multiple ways to enter the cell

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Regulation of blood pressure and salt homeostasis by endothelin

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Transactivation of epidermal growth factor receptor mediates catecholamine-induced growth of vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Receptor cleavage reduces the fluid shear response in neutrophils of the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Enhanced matrix metalloproteinase activity in the spontaneously hypertensive rat: VEGFR-2 cleavage, endothelial apoptosis, and capillary rarefaction

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Proteinase activity and receptor cleavage: mechanism for insulin resistance in the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

In Situ Zymography: A Molecular Pathology Technique to Localize Endogenous Protease Activity in Tissue Sections

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Protease proteomics: revealing protease in vivo functions using systems biology approaches

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Tumor imaging by means of proteolytic activation of cell-penetrating peptides

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

An emerging role of degrading proteinases in hypertension and the metabolic syndrome: autodigestion and receptor cleavage

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Persistent agonist-induced vasoconstriction is not required for angiotensin II to mediate inward remodeling of isolated arterioles with myogenic tone

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Delayed arteriolar relaxation after prolonged agonist exposure: functional remodeling involving tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinases and small artery remodeling

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Extracellular matrix alterations in hypertensive vascular remodeling

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Elastic properties and Windkessel function of the human aorta

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Role of transforming growth factor-beta in the progression of heart failure

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Cellular roles of ADAM12 in health and disease.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

ADAM-17: the enzyme that does it all.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Mice heterozygous for tumor necrosis factor-alpha converting enzyme are protected from obesity-induced insulin resistance and diabetes.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Avoiding spam in the proteolytic internet: future strategies for anti-metastatic MMP inhibition.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Contribution of plasma matrix metalloproteinases to development of left ventricular hypertrophy and diastolic dysfunction in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and -9 in essential hypertension

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Selective aspects of infective endocarditis: considerations on diagnosis, risk factors, treatment and prophylaxis

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Recent advances in MMP inhibitor design

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinase inhibitor development and the remodeling of drug discovery

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The history of the tetracyclines

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Inhibition of matrix metalloproteinase-2 improves endothelial function and prevents hypertension in insulin-resistant rats.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Long-term MMP inhibition by doxycycline exerts divergent effect on ventricular extracellular matrix deposition and systolic performance in stroke-prone spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Chronic doxycycline exposure accelerates left ventricular hypertrophy and progression to heart failure in mice after thoracic aorta constriction

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The use and safety of doxycycline hyclate and other second-generation tetracyclines.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

G-protein-coupled receptors as fat sensors.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome?

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Uncoupling proteins, dietary fat and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Mechanisms of insulin resistance in humans and possible links with inflammation

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Medicine. Low-power mitochondria may raise risk of cardiovascular problems.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Matrix metalloproteinase expression and activity following prostaglandin F(2 alpha)-induced luteolysis

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Statins and myocardial remodelling: cell and molecular pathways

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

An overview on biological mechanisms of PPARs.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more....

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

PPAR signaling in the control of cardiac energy metabolism

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

5,7-Dimethoxyflavone, an activator of PPARα/γ, inhibits UVB-induced MMP expression in human skin fibroblast cells.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Oleic acid content is responsible for the reduction in blood pressure induced by olive oil

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Localizing NADPH oxidase-derived ROS.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Regulation of matrix metalloproteinase (MMP) activity by the low-density lipoprotein receptor-related protein (LRP). A new function for an "old friend".

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Megalin- and cubilin-mediated endocytosis of protein-bound vitamins, lipids, and hormones in polarized epithelia

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The acute phase protein alpha2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1,2 and PI3-kinase/Akt pathways

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

LRP1 shedding in human brain: roles of ADAM10 and ADAM17.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

The hemopexin domain of matrix metalloproteinase-9 activates cell signaling and promotes migration of schwann cells by binding to low-density lipoprotein receptor-related protein

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Evidence that the newly cloned low-density-lipoprotein receptor related protein (LRP) is the alpha 2-macroglobulin receptor

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Cardiac isoform of alpha-2 macroglobin, a novel serum protein, may induce cardiac hypertrophy in rats

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

High-density lipoproteins prevent the oxidized low-density lipoprotein-induced epidermal [corrected] growth factor receptor activation and subsequent matrix metalloproteinase-2 upregulation.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Apolipoprotein A-IV is a novel substrate for matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Apolipoprotein C-II is a novel substrate for matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Analysis of apolipoprotein A-I as a substrate for matrix metalloproteinase-14.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Cleavage and functional loss of human apolipoprotein E by digestion of matrix metalloproteinase-14.

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Cleavage of apolipoprotein E by membrane-type matrix metalloproteinase-1 abrogates suppression of cell proliferation

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Structure-function relationships of apolipoprotein A-I: a flexible protein with dynamic lipid associations

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Filling Pressures and Collagen Metabolism in Hypertensive Patients With Heart Failure and Normal Ejection Fraction

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite

1 reference

https://api.crossref.org/works/10.1159%2F000345240

21 January 2018

Identifiers

10.1159/000345240

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38061567&oldid=1738931585"